Wikipedia / open kennis

Vandortuzumab vedotin

Vandortuzumab vedotin (INN; development code RG7450) is a humanized monoclonal antibody designed for the treatment of cancer.Statement On A Nonproprietary Name…

Vandortuzumab vedotin (INN; development code RG7450) is a humanized monoclonal antibody designed for the treatment of cancer.Statement On A Nonproprietary Name Adopted By The USAN Council - Vandortuzumab Vedotin, American Medical Association.

This drug was developed by Genentech/Roche. Development was discontinued in 2017.

References

Bron en licentie

Gebaseerd op: Wikipedia — Vandortuzumab vedotin · auteursgeschiedenis.

Tekst: CC BY-SA 4.0.

Over de bewerking

Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.